SAN DIEGO, Aug. 31, 2011 /PRNewswire/ -- Gen-Probe
Incorporated (NASDAQ: GPRO) announced today that the Company will
present at three upcoming investor conferences:
- Baird's 2011 Healthcare Conference in New York at 2:45 p.m.
Eastern Time (ET) on September
7;
- The Stifel Nicolaus 2011 Healthcare Conference in Boston at 9:45 a.m.
ET on September 8; and
- Morgan Stanley's Global Healthcare Conference in New York at 1:35 p.m.
ET on September 13.
The presentations will be webcast live and may be accessed
through a link on the investors section of Gen-Probe's website at
www.gen-probe.com. The webcasts will be available for 30 days
following the events.
About Gen-Probe
Gen-Probe is a global leader in the development, manufacture and
marketing of rapid, accurate and cost-effective molecular
diagnostic products and services that are used primarily to
diagnose human diseases, screen donated human blood, and ensure
transplant compatibility. Gen-Probe is headquartered in
San Diego and employs
approximately 1,400 people. For more information, go to
www.gen-probe.com.
Caution Regarding Forward-Looking Statements
Any statements in this press release about our expectations,
beliefs, plans, objectives, assumptions or future events or
performance are not historical facts and are forward-looking
statements. Forward-looking statements are not guarantees of
performance. They involve known and unknown risks, uncertainties
and assumptions that may cause actual results to differ materially
from those expressed or implied. For information about risks
and uncertainties we face and a discussion of our financial
statements and footnotes, see documents we have filed with the SEC,
including our most recent Form 10-K, and all subsequent periodic
filings. We assume no obligation and expressly disclaim any
duty to update any forward-looking statement to reflect events or
circumstances after the date of this press release or to reflect
the occurrence of unanticipated events.
Contact:
Paula Izidoro
Investor Relations
858-410-8904
SOURCE Gen-Probe Incorporated